Inhibikase Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
IKT
CUSIP
45719W205
Type
Equity
Class
COM NEW
Num filings
14
Total reported value, excl. options
$1.02 M
Manager Report Date Value ($000) Shares Option Type